Market Overview

Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

Related VRX
S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue To Rally
Yellen's Speech Not Enough To Keep Dow, S&P 500 In Positive Territory
Allergan Rebuffs Valeant's Tender Offer (Fox Business)
Related AGN
S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue To Rally
3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology
Allergan to Slash 13% of its Global Workforce (Fox Business)

Allergan Inc. (NYSE: AGN) shares bumped up more than 2 percent on a rumor that Hedge fund Paulson & Co. acquiredsix6 million shares.

The report by Reuters said Paulson backs Valeant Pharmaceuticals (NYSE: VRX) in its proxy battle to acquire Allergan and the new stake puts Paulson among Allergan's top holders.

Valeant needs support from 25 percent of Allergan's holders in order to call a special shareholder meeting to vote on its $53 billion bid.

Allergan has called the offer "grossly inadequate."

With a current market capitalization of about $50.3 billion, Allergan traded recently at $69.02, up 2.2 percent.

Posted-In: News Rumors

 

Related Articles (AGN + VRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters